Activist investors reshape Cardinal Health board following CEO shakeup


Cardinal Health has added four new independent directors, and two will not seek re-election, under an agreement with activist investor firm Elliott Investment Management L.P.

Previous AstraZeneca receives expanded FDA approval for multibillion-dollar cancer treatment
Next Liquidia faces delay for drug launch after ruling in United Therapeutics case